Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Evgen Pharma ( (GB:TCF) ) is now available.
TheraCryf PLC, a non-UK issuer, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights by T and I Limited. The notification indicates that T and I Limited now holds 7.5131% of the voting rights in TheraCryf, marking a notable shift in shareholder influence.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For a thorough assessment of TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue